Toll Free: 1-888-928-9744

Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2016 Update

Published: Mar 30, 2016 | Pages: 48 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology, and also diagnostic products.  The company offers these services to managed care organizations and other health insurance providers, clinicians, hospitals, ACOs and IDNs, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. The company is headquartered in Madison, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quest Diagnostics Incorporated
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents 
Table of Contents 2
List of Tables  4
List of Figures  5
Quest Diagnostics Incorporated Company Snapshot  6
Quest Diagnostics Incorporated Company Overview  6
Quest Diagnostics Incorporated Pipeline Products and Clinical Trials Overview  7
Quest Diagnostics Incorporated - Pipeline Analysis Overview  9
Business Description  9
Key Facts  10
Quest Diagnostics Incorporated - Major Products and Services  11
Quest Diagnostics Incorporated Pipeline Products by Development Stage  12
Quest Diagnostics Incorporated Pipeline Products Overview  14
AML/NPM1 - Acute Myelogenous Leukemia  14
AML/NPM1 - Acute Myelogenous Leukemia Product Overview  14
Celera Thrombophilia Genotyping Assay  15
Celera Thrombophilia Genotyping Assay Product Overview  15
Chimerism Assay - Transplant Rejection  16
Chimerism Assay - Transplant Rejection Product Overview  16
Diagnostic Test - Zika Virus  17
Diagnostic Test - Zika Virus Product Overview  17
Fragile - X Genotyping Assay  18
Fragile - X Genotyping Assay Product Overview  18
KIF6 Test - Coronary Heart Disease  19
KIF6 Test - Coronary Heart Disease Product Overview  19
Liver Fibrosis Genotyping Assay  20
Liver Fibrosis Genotyping Assay Product Overview  20
Lung Cancer Genotyping Assay  21
Lung Cancer Genotyping Assay Product Overview  21
LungDx  22
LungDx Product Overview  22
Simplexa Assay - Enterovirus  23
Simplexa Assay - Enterovirus Product Overview  23
Simplexa Test - MRSA  24
Simplexa Test - MRSA Product Overview  24
Spinal Muscular Atrophy Test  25
Spinal Muscular Atrophy Test Product Overview  25
VeraMarker BCR Test - LDT  26
VeraMarker BCR Test - LDT Product Overview  26
ViroSeq HBV Assay  27
ViroSeq HBV Assay Product Overview  27
ViroSeq HCV Assay  28
ViroSeq HCV Assay Product Overview  28
ViroSeq HIV Integrase Assay  29
ViroSeq HIV Integrase Assay Product Overview  29
Wellness Chip - Lung Cancer  30
Wellness Chip - Lung Cancer Product Overview  30
Quest Diagnostics Incorporated - Key Competitors  31
Quest Diagnostics Incorporated - Key Employees  32
Quest Diagnostics Incorporated - Key Employee Biographies  33
Quest Diagnostics Incorporated - Locations And Subsidiaries  34
Head Office  34
Other Locations & Subsidiaries  34
Recent Developments  38
Quest Diagnostics Incorporated, Recent Developments  38
Feb 24, 2016: Quest Diagnostics and Inovalon Bring Real-Time, Point-of-Care Analytics to HIMSS16 with Data Diagnostics  38
Feb 22, 2016: Quest Diagnostics to Showcase Its Advanced Healthcare Information Technology Solutions at HIMSS16 Under its New Quanum Brand  39
Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter  40
Jan 25, 2016: Clinical Genomics Presents Data Supporting Novel 2-Gene Blood Test for Earlier Detection of Colorectal Cancer Recurrence at ASCO GI  41
Jan 21, 2016: Clinical Genomics to Present Data Supporting Utility of 2-Gene Blood Test for Colorectal Cancer Recurrence at ASCO GI  42
Dec 10, 2015: Quest Diagnostics, Barnabas Health Enter Into Strategic Laboratory Partnership To Deliver High-value And Innovative Diagnostic Information Services  43
Oct 22, 2015: Quest Diagnostics Reports Third Quarter 2015 Financial Results  44
Oct 06, 2015: FDA Clears the Focus Diagnostics Simplexa Flu A/B & RSV Direct Test to Include 53 New Virus Strains for the 2015-2016 Flu Season  44
Sep 29, 2015: Quest Diagnostics and Inovalon Advance Value-Based Healthcare with Industry-First Real-Time Analytics at the Point of Care  45
Sep 03, 2015: Focus Diagnostics Receives FDA Clearance to Add Genital Swab Claim to Moderate Complexity Simplexa HSV 1 & 2 Direct Molecular Test  47
Appendix  48
Methodology  48
About GlobalData  48
Contact Us  48
Disclaimer  48
List of Tables
Quest Diagnostics Incorporated Pipeline Products and Clinical Trials Overview  7
Quest Diagnostics Incorporated Pipeline Products by Equipment Type  7
Quest Diagnostics Incorporated Pipeline Products by Indication  8
Quest Diagnostics Incorporated, Key Facts  10
Quest Diagnostics Incorporated, Major Products and Services  11
Quest Diagnostics Incorporated Number of Pipeline Products by Development Stage  12
Quest Diagnostics Incorporated Pipeline Products Summary by Development Stage  13
AML/NPM1 - Acute Myelogenous Leukemia - Product Status  14
AML/NPM1 - Acute Myelogenous Leukemia - Product Description  14
Celera Thrombophilia Genotyping Assay - Product Status  15
Celera Thrombophilia Genotyping Assay - Product Description  15
Chimerism Assay - Transplant Rejection - Product Status  16
Chimerism Assay - Transplant Rejection - Product Description  16
Diagnostic Test - Zika Virus - Product Status  17
Diagnostic Test - Zika Virus - Product Description  17
Fragile - X Genotyping Assay - Product Status  18
Fragile - X Genotyping Assay - Product Description  18
KIF6 Test - Coronary Heart Disease - Product Status  19
KIF6 Test - Coronary Heart Disease - Product Description  19
Liver Fibrosis Genotyping Assay - Product Status  20
Liver Fibrosis Genotyping Assay - Product Description  20
Lung Cancer Genotyping Assay - Product Status  21
Lung Cancer Genotyping Assay - Product Description  21
LungDx - Product Status  22
LungDx - Product Description  22
Simplexa Assay - Enterovirus - Product Status  23
Simplexa Assay - Enterovirus - Product Description  23
Simplexa Test - MRSA - Product Status  24
Simplexa Test - MRSA - Product Description  24
Spinal Muscular Atrophy Test - Product Status  25
Spinal Muscular Atrophy Test - Product Description  25
VeraMarker BCR Test - LDT - Product Status  26
VeraMarker BCR Test - LDT - Product Description  26
ViroSeq HBV Assay - Product Status  27
ViroSeq HBV Assay - Product Description  27
ViroSeq HCV Assay - Product Status  28
ViroSeq HCV Assay - Product Description  28
ViroSeq HIV Integrase Assay - Product Status  29
ViroSeq HIV Integrase Assay - Product Description  29
Wellness Chip - Lung Cancer - Product Status  30
Wellness Chip - Lung Cancer - Product Description  30
Quest Diagnostics Incorporated, Key Employees  32
Quest Diagnostics Incorporated, Key Employee Biographies  33
Quest Diagnostics Incorporated, Subsidiaries  34 


List of Figures
Quest Diagnostics Incorporated Pipeline Products by Equipment Type  8
Quest Diagnostics Incorporated Pipeline Products by Development Stage  12

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expe

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify